Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00263731 · ClinicalTrials.gov registry record
Metabolomic Analysis of Lung Cancer
A clinical trial, sponsored by University of Louisville.
- Completed
- Registry status
- 249
- Enrollment target
NCT00263731: Completed study, sponsored by University of Louisville.
NCT00263731 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 249 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00263731 has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 249 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the metabolic properties of lung cancer cells.
Interventions
- OTHER 13-C-glucose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 249 participants |
| Start Date | 2005-12 |
| Est. Completion | 2020-09-24 |
What the finished NCT00263731 record still lists
NCT00263731 is an observational study that tracks outcomes without assigning an intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which 13-C-glucose is the first listed.
NCT00263731 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00263731 about?
NCT00263731 is a clinical study titled "Metabolomic Analysis of Lung Cancer". The purpose of this study is to learn more about the metabolic properties of lung cancer cells.
What is the current status of trial NCT00263731?
This trial is currently completed. The enrollment target is 249 participants. The study started on 2005-12. Estimated completion is 2020-09-24.
What interventions are being tested in trial NCT00263731?
The interventions under investigation include: 13-C-glucose (OTHER).
Who is sponsoring clinical trial NCT00263731?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04628767 · 249 participants · Phase 2
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
- NCT05834907 · 249 participants · NA
Hands and Hearts Together
- NCT06067555 · 249 participants · Early Phase 1
Intradermal Influenza Vaccination
- NCT06588478 · 249 participants · Phase 2
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia